Synairgen (SNG) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 May 2013 11:10 AM
RNS
Holding(s) in Company
09 May 2013 12:45 PM
RNS
Notice of AGM
09 Apr 2013 04:26 PM
RNS
Posting of Annual Report
12 Mar 2013 07:00 AM
RNS
Grant of Options
13 Feb 2013 07:00 AM
RNS
Preliminary Results
05 Dec 2012 07:00 AM
RNS
Trading Update
30 Oct 2012 01:44 PM
RNS
Director/PDMR Shareholding
25 Sep 2012 07:00 AM
RNS
Exercise of Options
31 Aug 2012 07:00 AM
RNS
Synairgen presents proof of concept study
10 Aug 2012 07:00 AM
RNS
Half Yearly Report
18 Jul 2012 07:00 AM
RNS
Placing
25 Jun 2012 01:30 PM
RNS
Result of AGM
22 May 2012 07:30 AM
RNS
Professor Stephen Holgate given prestigious Award
01 May 2012 12:55 PM
RNS
Holding(s) in Company
19 Apr 2012 07:00 AM
RNS
Positive Phase II asthma data
02 Mar 2012 07:00 AM
RNS
Notice of Report and Accounts
01 Feb 2012 07:00 AM
RNS
Preliminary results
30 Jan 2012 07:00 AM
RNS
Notice of Results
12 Dec 2011 07:00 AM
RNS
Director's dealing
08 Dec 2011 07:00 AM
RNS
End of Recruitment in Phase II Asthma Trial
25 Nov 2011 07:00 AM
RNS
Positive Viral Pneumonia Study Results
10 Nov 2011 12:40 PM
RNS
Result of AGM
18 Oct 2011 01:50 PM
RNS
Notice of AGM and posting of Annual Reports
22 Sep 2011 03:10 PM
RNS
Grant of options
13 Sep 2011 07:00 AM
RNS
Preliminary Results
09 Sep 2011 07:00 AM
RNS
Change of Adviser
18 Jul 2011 07:00 AM
RNS
Japanese Patent to be Granted
28 Jun 2011 07:00 AM
RNS
Phase II asthma study - Interim Review and update
15 Jun 2011 03:56 PM
RNS
Holding(s) in Company
13 Jun 2011 11:54 AM
RNS
Result of General Meeting
27 May 2011 01:00 PM
RNS
Fundraising
04 May 2011 07:00 AM
RNS
Antiviral activity against Bird Flu
02 Feb 2011 11:31 AM
RNS
Holding(s) in Company
01 Feb 2011 07:00 AM
RNS
Half Yearly Report
03 Nov 2010 01:35 PM
RNS
Result of AGM
19 Oct 2010 07:00 AM
RNS
US Patent
08 Oct 2010 09:00 AM
RNS
Notice of AGM and Posting of
09 Sep 2010 07:00 AM
RNS
Grant of Options
29 Jul 2010 07:00 AM
RNS
Final Results
27 Jul 2010 07:00 AM
RNS
Notice of Results
29 Jun 2010 07:00 AM
RNS
Grant of Options
28 Jun 2010 07:00 AM
RNS
Directorate Change
17 May 2010 07:00 AM
RNS
Positive Influenza Data
06 May 2010 07:00 AM
RNS
IFN-beta Patent Granted in Eu
01 Apr 2010 07:00 AM
RNS
Phase II Trials
24 Feb 2010 03:27 PM
RNS
Holding(s) in Company
08 Feb 2010 07:00 AM
RNS
Half Yearly Report
15 Jan 2010 07:00 AM
RNS
Holding(s) in Company
12 Nov 2009 07:00 AM
RNS
Successful Outcome of Phase 1
11 Nov 2009 01:24 PM
RNS
Result of AGM

Synairgen is a University spin-off and public limited company working in drug discovery and biotechnology. It was founded in 2003 by University of Southampton professors Stephen Holgate, Donna E. Davies and Ratko Djukanovic.

Synairgen is a specialist respiratory biotech company whose primary focus is developing our investigative inhaled interferon beta candidate (SNG001) for severe viral lung infections.

Synairgen share price launched at 155p in 2004.

UK 100

Latest directors dealings